Clarius Group, LLC Edwards Lifesciences Corp Transaction History

Clarius Group, LLC

  • $1.44 Billion
  • Q4 2024

A detailed history of Clarius Group, LLC transactions in Edwards Lifesciences Corp stock. As of the latest transaction made, Clarius Group, LLC holds 4,847 shares of EW stock, worth $369,292. This represents 0.02% of its overall portfolio holdings.

Number of Shares
4,847
Previous 4,443 9.09%
Holding current value
$369,292
Previous $293,000 22.18%
% of portfolio
0.02%
Previous 0.02%

Shares

23 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Jan 15, 2025
BUY
$64.54 - $75.92 $26,074 - $30,671
404 Added 9.09%
4,847 $358,000
Q3 2024

Oct 09, 2024
SELL
$59.7 - $93.78 $6,447 - $10,128
-108 Reduced 2.37%
4,443 $293,000
Q2 2024

Jul 11, 2024
SELL
$84.3 - $94.31 $9,357 - $10,468
-111 Reduced 2.38%
4,551 $420,000
Q1 2024

Apr 17, 2024
SELL
$72.54 - $95.56 $47,658 - $62,782
-657 Reduced 12.35%
4,662 $445,000
Q4 2023

Jan 29, 2024
SELL
$61.71 - $77.76 $77,014 - $97,044
-1,248 Reduced 19.0%
5,319 $405,000
Q3 2023

Oct 19, 2023
SELL
$69.28 - $93.38 $138,767 - $187,040
-2,003 Reduced 23.37%
6,567 $454,000
Q2 2023

Aug 09, 2023
BUY
$81.41 - $94.33 $31,668 - $36,694
389 Added 4.75%
8,570 $808,000
Q1 2023

Apr 17, 2023
BUY
$74.26 - $84.51 $14,703 - $16,732
198 Added 2.48%
8,181 $676,000
Q4 2022

Jan 25, 2023
SELL
$68.3 - $87.44 $4,507 - $5,771
-66 Reduced 0.82%
7,983 $596,000
Q3 2022

Oct 24, 2022
SELL
$82.37 - $107.29 $4,859 - $6,330
-59 Reduced 0.73%
8,049 $665,000
Q2 2022

Aug 10, 2022
BUY
$86.5 - $128.27 $98,091 - $145,458
1,134 Added 16.26%
8,108 $771,000
Q4 2021

Feb 02, 2022
BUY
$106.37 - $130.68 $6,275 - $7,710
59 Added 0.85%
6,974 $903,000
Q3 2021

Oct 18, 2021
BUY
$102.91 - $122.75 $26,550 - $31,669
258 Added 3.88%
6,915 $783,000
Q2 2021

Aug 06, 2021
BUY
$83.84 - $104.76 $7,629 - $9,533
91 Added 1.39%
6,657 $689,000
Q1 2021

Apr 27, 2021
BUY
$78.68 - $90.67 $27,380 - $31,553
348 Added 5.6%
6,566 $549,000
Q4 2020

Jan 15, 2021
BUY
$71.69 - $91.23 $88,035 - $112,030
1,228 Added 24.61%
6,218 $567,000
Q3 2020

Oct 09, 2020
BUY
$67.19 - $87.44 $21,635 - $28,155
322 Added 6.9%
4,990 $398,000
Q2 2020

Jul 08, 2020
BUY
$57.54 - $76.95 $183,955 - $246,009
3,197 Added 217.34%
4,668 $323,000
Q1 2020

Apr 24, 2020
SELL
$52.41 - $81.0 $3,563 - $5,508
-68 Reduced 4.42%
1,471 $277,000
Q4 2019

Jan 22, 2020
SELL
$71.7 - $82.09 $4,875 - $5,582
-68 Reduced 4.23%
1,539 $364,000
Q3 2019

Oct 23, 2019
BUY
$61.55 - $75.43 $16,003 - $19,611
260 Added 19.3%
1,607 $353,000
Q2 2019

Aug 02, 2019
BUY
$55.74 - $64.41 $10,925 - $12,624
196 Added 17.03%
1,347 $249,000
Q1 2019

May 14, 2019
BUY
$47.89 - $64.05 $55,121 - $73,721
1,151 New
1,151 $220,000

Others Institutions Holding EW

# of Institutions
1,381
Shares Held
474M
Call Options Held
8.62M
Put Options Held
4.03M
View Full List

About Edwards Lifesciences Corp

EW Quotes by TradingView
  • Ticker EW
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 618,259,968
  • Market Cap $47.1B
  • Description
  • Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...
More about EW
Track This Portfolio

Track Clarius Group, LLC Portfolio

Follow Clarius Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Clarius Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Clarius Group, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email